Home > Insider Trading > Filing (0001062993-21-008244)

Filing Details

Accession Number:: 0001062993-21-008244
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-03 17:05:47
Reporting Period:: 2021-09-01

Accepted Time:: 2021-09-03 17:05:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
12208	Bio-Rad Laboratories Inc.	BIO BIOB	Laboratory Analytical Instruments (3826)	941381833

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1485088	J. Andrew Last	C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547	Evp, Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Bio-Rad A Common Stock	Acquisiton	2021-09-01	2,000	$299.24	3,282	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2021-09-01	750	$812.27	2,532	No	4	S	Direct
Bio-Rad A Common Stock	Disposition	2021-09-01	651	$813.15	1,881	No	4	S	Direct
Bio-Rad A Common Stock	Disposition	2021-09-01	599	$814.09	1,282	No	4	S	Direct
Bio-Rad A Common Stock	Acquisiton	2021-09-02	902	$0.00	2,184	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2021-09-02	448	$825.77	1,736	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Bio-Rad A Common Stock	Restricted Stock Units	Acquisiton	2021-09-01	2,532	$0.00	2,532	$0.00
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2021-09-01	2,532	$0.00	2,532	$814.95
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-09-01	2,000	$0.00	2,000	$299.24
Bio-Rad A Common Stock	Restricted Stock Units	Disposition	2021-09-02	902	$0.00	902	$0.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,532		No	4	A	Direct
2,532	2031-09-01	No	4	A	Direct
3,000	2029-04-29	No	4	M	Direct
2,708		No	4	M	Direct

Footnotes

Includes 13.9278 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $811.70 to $812.69, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $812.71 to $813.34, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $814.02 to $814.11, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares of Class A common stock acquired on the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2020, which was the first anniversary of the date on which the option was granted.
On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.